Express Gene™ Comprehensive Pharmacogenomics (PGX) – Provider

Test Code: 040A

Test Overview

Personalized genetic testing for drug response and compatibility, designed to optimize your medication regimen by identifying how your unique genetic makeup influences drug metabolism, effectiveness, and potential side effects.

Key Features

Our Comprehensive Pharmacogenomics (PGX) panel offers tailored medication recommendations based on individual genetic profiles, ensuring safer and more effective treatments. This advanced test analyzes targeted SNPs (single nucleotide polymorphisms) in 38 key genes that are integral to drug response and metabolism. By providing insights into genetic variants, this panel helps healthcare providers manage potential risks, adjust dosages, and develop personalized therapeutic plans for patients.

Genes Covered: The test covers a comprehensive range of genes associated with drug metabolism and response, including:

  • Transporters and Enzymes: ABCB1, ABCG2, CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLC28A3, SLC47A2, SLCO1B1, UGT1A6, UGT2B15.
  • Receptors and Channels: ADRA2A, ADRB2, DRD2, HTR2A, OPRM1.
  • Others: ADH1B, ANKK1, APOE, C11orf65, COMT, F13A1, F2, F5, GRIK4, HLA-A, IFNL3, ITGB3, MTHFR, NOS3, RARG, TPMT, VKORC1.

This extensive panel enables precise predictions of individual responses to various medications, reducing the risk of adverse effects and improving therapeutic outcomes. By understanding your genetic profile, healthcare providers can make more informed decisions, tailor treatments, and enhance overall patient care.

Test Options

Customize your order and select preferred genes


Product total
Options total
Grand total
    Your Cart
    Your cart is emptyReturn to Shop